150 related articles for article (PubMed ID: 37570658)
1. Synthesis of Pseudooligosaccharides Related to the Capsular Phosphoglycan of
Kamneva AA; Yashunsky DV; Khatuntseva EA; Nifantiev NE
Molecules; 2023 Jul; 28(15):. PubMed ID: 37570658
[TBL] [Abstract][Full Text] [Related]
2. Syntheses of anomerically phosphodiester-linked oligomers of the repeating units of the Haemophilus influenzae types c and f capsular polysaccharides.
Hansson J; Garegg PJ; Oscarson S
J Org Chem; 2001 Sep; 66(19):6234-43. PubMed ID: 11559168
[TBL] [Abstract][Full Text] [Related]
3. Cross-reactivity of Haemophilus influenzae type a and b polysaccharides: molecular modeling and conjugate immunogenicity studies.
Richardson NI; Kuttel MM; Michael FS; Cairns C; Cox AD; Ravenscroft N
Glycoconj J; 2021 Dec; 38(6):735-746. PubMed ID: 34491462
[TBL] [Abstract][Full Text] [Related]
4. Invasive infections with Haemophilus influenzae serotype a containing an IS1016-bexA partial deletion: possible association with virulence.
Kapogiannis BG; Satola S; Keyserling HL; Farley MM
Clin Infect Dis; 2005 Dec; 41(11):e97-103. PubMed ID: 16267724
[TBL] [Abstract][Full Text] [Related]
5. [Dynamics of growth of Haemophilus influenzae serotype B and synthesis of capsular polysaccharide in the process of cultivation in a synthetic nutrient medium].
Orlova OE
Zh Mikrobiol Epidemiol Immunobiol; 2002; (2):75-7. PubMed ID: 12043160
[TBL] [Abstract][Full Text] [Related]
6. [Surveillance of Haemophilus influenzae serotypes in Argentina from 2005 to 2010 during the Haemophilus influenzae type b conjugate vaccine era].
Efron AM; Moscoloni MA; Reijtman VR; Regueira M
Rev Argent Microbiol; 2013; 45(4):240-7. PubMed ID: 24401777
[TBL] [Abstract][Full Text] [Related]
7. Identification and quantitation of capsular antigen in capsulated and noncapsulated strains of Haemophilus influenzae type b by crossed-immunoelectrophoresis.
Buckmire FL
Infect Immun; 1976 Jun; 13(6):1733-42. PubMed ID: 1085750
[TBL] [Abstract][Full Text] [Related]
8. Molecular Serotype-Specific Identification of Non-type b
Takano C; Seki M; Kim DW; Kilgore PE; Fuwa K; Takahashi K; Inazaki T; Hayakawa S
Front Microbiol; 2017; 8():1877. PubMed ID: 29046666
[TBL] [Abstract][Full Text] [Related]
9. Latex agglutination test for screening of Haemophilus influenzae type b carriers.
Heikkilä R; Takala A; Käyhty H; Leinonen M
J Clin Microbiol; 1987 Jun; 25(6):1131-3. PubMed ID: 3496356
[TBL] [Abstract][Full Text] [Related]
10. Invasive serotype a Haemophilus influenzae infections with a virulence genotype resembling Haemophilus influenzae type b: emerging pathogen in the vaccine era?
Adderson EE; Byington CL; Spencer L; Kimball A; Hindiyeh M; Carroll K; Mottice S; Korgenski EK; Christenson JC; Pavia AT
Pediatrics; 2001 Jul; 108(1):E18. PubMed ID: 11433097
[TBL] [Abstract][Full Text] [Related]
11. Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory.
Käyhty H; Karanko V; Peltola H; Mäkelä PH
Pediatrics; 1984 Nov; 74(5):857-65. PubMed ID: 6387614
[TBL] [Abstract][Full Text] [Related]
12. PCR for capsular typing of Haemophilus influenzae.
Falla TJ; Crook DW; Brophy LN; Maskell D; Kroll JS; Moxon ER
J Clin Microbiol; 1994 Oct; 32(10):2382-6. PubMed ID: 7814470
[TBL] [Abstract][Full Text] [Related]
13. Antigenic heterogeneity of immunoglobulin A1 proteases from encapsulated and non-encapsulated Haemophilus influenzae.
Kilian M; Thomsen B
Infect Immun; 1983 Oct; 42(1):126-32. PubMed ID: 6194113
[TBL] [Abstract][Full Text] [Related]
14. Surface determinants of Haemophilus influenzae pathogenicity: comparative virulence of capsular transformants in normal and complement-depleted rats.
Zwahlen A; Winkelstein JA; Moxon ER
J Infect Dis; 1983 Sep; 148(3):385-94. PubMed ID: 6604759
[TBL] [Abstract][Full Text] [Related]
15. Capsular serotyping of Haemophilus influenzae by using matrix-associated laser desorption ionization-time of flight mass spectrometry.
Takeuchi N; Segawa S; Ishiwada N; Ohkusu M; Tsuchida S; Satoh M; Matsushita K; Nomura F
J Infect Chemother; 2018 Jul; 24(7):510-514. PubMed ID: 29534849
[TBL] [Abstract][Full Text] [Related]
16. Cloning of chromosomal DNA from Haemophilus influenzae. Its use for studying the expression of type b capsule and virulence.
Moxon ER; Deich RA; Connelly C
J Clin Invest; 1984 Feb; 73(2):298-306. PubMed ID: 6607932
[TBL] [Abstract][Full Text] [Related]
17. Type b capsular polysaccharide as a virulence factor of Haemophilus influenzae.
Moxon ER; Kroll JS
Vaccine; 1988 Apr; 6(2):113-5. PubMed ID: 3291448
[TBL] [Abstract][Full Text] [Related]
18. Investigating the candidacy of a capsular polysaccharide-based glycoconjugate as a vaccine to combat Haemophilus influenzae type a disease: A solution for an unmet public health need.
Cox AD; Williams D; Cairns C; St Michael F; Fleming P; Vinogradov E; Arbour M; Masson L; Zou W
Vaccine; 2017 Oct; 35(45):6129-6136. PubMed ID: 28951087
[TBL] [Abstract][Full Text] [Related]
19. Distribution and excretion of capsular antigen after immunization with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
Sood SK; Ballanco GA; Mather FJ; Pramberg JC; Daum RS
J Infect Dis; 1990 Mar; 161(3):574-7. PubMed ID: 2107266
[TBL] [Abstract][Full Text] [Related]
20. A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan.
Suga S; Ishiwada N; Sasaki Y; Akeda H; Nishi J; Okada K; Fujieda M; Oda M; Asada K; Nakano T; Saitoh A; Hosoya M; Togashi T; Matsuoka M; Kimura K; Shibayama K
Vaccine; 2018 Sep; 36(38):5678-5684. PubMed ID: 30122645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
